Efficacy and safety of guselkumab in patients with active lupus nephritis: results from a phase 2, randomized, placebo-controlled study. - Anders HJ; Chan TM; Sanchez-Guerrero J; Wofsy D; Bensley K; Kim L; Lo KH; Shu C; Shao J; Karyekar CS; Diamond B (Rheumatology (Oxford, England), 2025)